Risankizumab

Item number	Size	Delivery time	Price
TGM-T76778-1mg	1 mg	7 - 10 business days*	242.00€
TGM-T76778-5mg	5 mg	7 - 10 business days*	792.00€
TGM-T76778-10mg	10 mg	7 - 10 business days*	1,229.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Risankizumab (BI 655066) is a humanized IgG monoclonal antibody (Kd <10 pM)... more

Close menu

Product information "Risankizumab"

Description: Risankizumab (BI 655066) is a humanized IgG monoclonal antibody (Kd <10 pM) targeting the IL-23 p19 subunit. It inhibits IL-17 production induced by human IL-23 in mouse splenocytes with an IC50 value of 2 pM. Risankizumab is used for the prevention and treatment of immune and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis. Target: IL Receptor. References: McKeage K, Duggan S. Risankizumab: First Global Approval. Drugs. 2019 Jun,79(8):893-900.

Keywords:	BI-655066, ABBV 066, Risankizumab rzaa, SKYRIZI
Supplier:	TargetMol
Supplier-Nr:	T76778

Properties

Application:	Targets interleukin 23 subunit alpha (IL23A)
Conjugate:	No

Database Information

CAS :	1612838-76-2\| Matching products
KEGG ID :	K05426 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Risankizumab"

Write a review